输血仍旧在肝癌的外科治疗中占有重要地位。然而异体输血可能导致受血者免疫抑制,阻碍机体对肿瘤的免疫应答,促进肿瘤转移复发。如何解决这一矛盾,值得我们的关注。我们要研究异体输血与肝癌肝切除术后转移复发的关系,从而找出对策,改善肝癌患者预后水平。
Blood transfusion in liver surgery still plays an important role. However, blood transfusions may cause immunosuppression recipients and hinder the body' s immune response against the tumor, promotes tumor metastasis and recurrence. How to resolve this contradiction? We must study and research the effects of allogeneic blood transfusion on liver cancer metastasis and recurrence after hepatic resection, and to find strategies to improve the liver cancer prognosis.